New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis

Despite advances in the treatment of hepatocellular carcinoma (HCC), managing HCC with portal vein thrombosis (PVT) remains challenging. PVT is present in 10-40% of HCC cases at the time of diagnosis and its therapeutic options are very limited. Current guidelines mainly recommend sorafenib for adva...

Descripción completa

Detalles Bibliográficos
Autores principales: Woo, Hyun Young, Heo, Jeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493353/
https://www.ncbi.nlm.nih.gov/pubmed/26157747
http://dx.doi.org/10.3350/cmh.2015.21.2.115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493353/
https://www.ncbi.nlm.nih.gov/pubmed/26157747
http://dx.doi.org/10.3350/cmh.2015.21.2.115

Ejemplares similares